ATE141605T1 - Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen - Google Patents

Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen

Info

Publication number
ATE141605T1
ATE141605T1 AT89101581T AT89101581T ATE141605T1 AT E141605 T1 ATE141605 T1 AT E141605T1 AT 89101581 T AT89101581 T AT 89101581T AT 89101581 T AT89101581 T AT 89101581T AT E141605 T1 ATE141605 T1 AT E141605T1
Authority
AT
Austria
Prior art keywords
compounds
pharmaceutical uses
thienotriazoldiazepine
paf
chem
Prior art date
Application number
AT89101581T
Other languages
English (en)
Inventor
Minoru Moriwaki
Hiroshi Tanaka
Michio Terasawa
Tetsuya Tahara
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Application granted granted Critical
Publication of ATE141605T1 publication Critical patent/ATE141605T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AT89101581T 1988-01-30 1989-01-30 Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen ATE141605T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2040088 1988-01-30
JP10322188 1988-04-26
JP30836588 1988-12-06
JP31168888 1988-12-08

Publications (1)

Publication Number Publication Date
ATE141605T1 true ATE141605T1 (de) 1996-09-15

Family

ID=27457375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89101581T ATE141605T1 (de) 1988-01-30 1989-01-30 Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen

Country Status (7)

Country Link
US (1) US4937240A (de)
EP (1) EP0328924B1 (de)
KR (1) KR910004448B1 (de)
AT (1) ATE141605T1 (de)
CA (1) CA1324863C (de)
DE (1) DE68926972T2 (de)
ES (1) ES2095208T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
DE4010528A1 (de) * 1990-04-02 1991-10-17 Boehringer Ingelheim Kg Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
DE4027470A1 (de) * 1990-08-30 1992-03-05 Boehringer Ingelheim Kg Neue hetrazepinoide amide
JP2959598B2 (ja) * 1990-10-12 1999-10-06 吉富製薬株式会社 光学活性なチエノトリアゾロジアゼピン化合物
DE4107521A1 (de) * 1991-03-08 1992-09-10 Boehringer Ingelheim Kg Neue acylaminosubstituierte hetrazepine
EP1937663A1 (de) * 2005-09-29 2008-07-02 Inpharmatica Limited Thiophenderivate als ppar-agonisten i
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9422292B2 (en) 2011-05-04 2016-08-23 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
EP2864336B1 (de) 2012-06-06 2016-11-23 Constellation Pharmaceuticals, Inc. Benzo[b]isoxazolazepinbromdomänenhemmer und verwendungen davon
EP3157928B1 (de) 2014-06-20 2019-02-13 Constellation Pharmaceuticals, Inc. Kristalline formen von 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamid

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994941A (en) * 1975-10-20 1976-11-30 The Upjohn Company Preparation of 1-(2-phthalimidoethyl)-4H-s-tiazolo[4,3-a][1,4]benzodiazepines
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
ES2037013T3 (es) * 1986-01-21 1993-06-16 Boehringer Ingelheim Kg Procedimiento para preparar tieno-1,4-diazepinas.
DE3610848A1 (de) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg Neue 1,4-diazepine
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
US4960770A (en) * 1987-05-28 1990-10-02 Yoshitomi Pharmaceutical Industries, Ltd. 2-alkyl thieno(triazolo)diazepine compounds and pharmaceutical uses thereof
WO1988009792A1 (en) * 1987-06-08 1988-12-15 Yoshitomi Pharmaceutical Industries, Ltd. Ester-substituted thienotriazolodiazepine compounds and their medicinal use
EP0368175A1 (de) * 1988-11-06 1990-05-16 Boehringer Ingelheim Kg 3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin.

Also Published As

Publication number Publication date
KR910004448B1 (ko) 1991-06-29
KR890011892A (ko) 1989-08-23
CA1324863C (en) 1993-11-30
ES2095208T3 (es) 1997-02-16
DE68926972D1 (de) 1996-09-26
US4937240A (en) 1990-06-26
EP0328924A3 (de) 1991-03-20
EP0328924B1 (de) 1996-08-21
EP0328924A2 (de) 1989-08-23
DE68926972T2 (de) 1997-01-16

Similar Documents

Publication Publication Date Title
BR0211228A (pt) Composto, composição farmacêutica e seus usos
SE9604786D0 (sv) New compounds
MX9203543A (es) Medicamento.
HU913283D0 (en) Process for the production of hydroximethyl-(methylene-cyclopentyl)-purines and pirimidines, their medically usable salts, and of medical preparations containing them
DE3779500D1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
DE3888441D1 (de) Benzoxazin-Verbindungen und ihre pharmazeutische Anwendung.
ES2070628T3 (es) Uso de compuestos analogos a 1,3-oxatiolano-nucleosidos en la fabricacion de un medicamento para el tratamiento de la hepatitis b.
NO306464B1 (no) Benzimidazolforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene for fremstilling av medikamenter
ATE235482T1 (de) Isocumarinderivate und deren verwendung in medikamenten
FR2678938B1 (fr) Derives de pyrrolidine, leur preparation et les medicaments les contenant.
DE68917485D1 (de) Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen.
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
DE3881073D1 (de) Naphthalenverbindungen und antiallergische und antiinflammatorische pharmazeutische mittel.
ES2163425T3 (es) Uso de raloxifeno y de sus analogos para la fabricacion de un medicamento para el tratamiento de la ateroesclerosis y la enfermedad cardiaca isquemica.
ATE173627T1 (de) Medizinische zusammensetzung
ATE114154T1 (de) Thienotriazolodiazepine und ihre pharmazeutische verwendung.
ATE161531T1 (de) Acridine-1,8-dionderivate als therapeutisches mittel
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
ATE117724T1 (de) Antibiotikum ge 22270, faktoren a1,a2,a3 und h.
EP0535250A4 (en) Novel compounds and use thereof as medicine
DE3872425D1 (de) Substituierte tetrahydroisochinolin-verbindungen, ihre herstellung und diese enthaltende pharmazeutische mittel.
DE68922035D1 (de) Glyzerin-Derivat und dessen pharmazeutische Verwendung.
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
ATE140922T1 (de) 3- oder 4-glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches mittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee